|
PARTIAL CLIENT LIST Key Relationships: Abbott laboratories Affymax Alexandria Real Estate Equities Biomembrane Institute Bristol-Myers Squibb Calypso Medical Technologies Celltech Chiroscience Ceptyr Cerep Combimatrix Corus Pharma Darwin Molecular Corporation Fred Hutchinson Cancer GE Medical Genetic Systems (BIORAD) Halosource Corporation Hewlett-Packard Hexos Hope Heart Institute Icos Illumigen Infectious Disease Research Intitute Institute for Systems Biology Intracel Micronics Microprobe Omeros Oridigm Pathogenesis Phenogenomics Corporation Plexus Corporation Procyte Research Center Scitech Seattle Biomedical Research Institute Seattle Genetics Sonus Pharmaceuticals Touchstone Corporation |
Bill Neil
Senior Vice President
425.454.7040 /
bneil@gvakm.com
Career Highlights
Bill Neil, a principal and past member of the Board of Directors of GVA Kidder Mathews, specializes in representing corporate clients in lease negotiations and corporate real estate matters in the greater Seattle-area and throughout North America. He is consistently honored as a GVA Kidder Mathews “Big Hitter,” having achieved a top 10 ranking in terms of revenue performance, out of 125 agents, in each of the last ten years.
Bill has extensive experience working with wet laboratory tenants, having represented many of Seattle’s preeminent biotechnology companies and non-profit research institutions. He and his partner, John Cox: sold the 276,000 square foot Fred Hutchinson Cancer Research Center’s First Hill Properties, enabling the “Hutch” to break ground on Phase 2 of its multi-phase Lake Union Campus; handled the divestiture of the 132,000 square foot Bristol-Myers Squibb Pharmaceutical Research Institute in Seattle; and represented Alexandria Real Estate Equities in the acquisitions of both the $52.2 million dollar acquisition of Zymogenetics’ 158,000 square feet multi-building assets on Lake Union and the $34 million dollar 168,000 square foot 1616 Eastlake Building constructed to accommodate life science laboratory users.
Additionally, Bill and John completed seven of the largest life science real estate leases in the Seattle area, including: Corixa for 139,300 square feet; Fred Hutchinson Cancer Research Center for 100,000 square feet; CombiMatrix for 92,000 square feet; Seattle Genetics for 63,000 square feet; the Institute for Systems Biology for 55,140 square feet; ICOS (four leases) for 152,000 square feet; and CEPTYR for 34,000 square feet.
Bill is an acknowledged leader in Seattle’s life science industry real estate market. He is an active member of the WBBA, is a regular speaker on the life science real estate market at commercial real estate symposiums and has authored biotechnology-oriented articles in Seattle newspapers and industry-related trade journals.
Bill presented the Seattle Area’s 2003 Biotechnology/Life Science Industry Overview at NAIOP’s Annual Forecast Breakfast in January 2003. Additionally, Bill was nominated for the “SIOR Broker of the Year Award” in 1995, 1998, and 2003, and, along with his partner, was nominated as the recipient of the “NAIOP Most Creative Deal Award” in 1996 and 1998.